1. Home
  2. QTTB vs AHRT Comparison

QTTB vs AHRT Comparison

Compare QTTB & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$15.68

Market Cap

450.1M

Sector

Health Care

ML Signal

HOLD

Logo AH Realty Trust Inc. Common Stock

AHRT

AH Realty Trust Inc. Common Stock

N/A

Current Price

$6.96

Market Cap

539.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
AHRT
Founded
2015
1979
Country
United States
United States
Employees
N/A
98
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
450.1M
539.3M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
QTTB
AHRT
Price
$15.68
$6.96
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$13.00
$7.00
AVG Volume (30 Days)
2.0M
604.3K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
9.30%
EPS Growth
136.78
N/A
EPS
N/A
N/A
Revenue
$53,737,000.00
N/A
Revenue This Year
N/A
$854.92
Revenue Next Year
N/A
$11.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$5.13
52 Week High
$23.57
$7.20

Technical Indicators

Market Signals
Indicator
QTTB
AHRT
Relative Strength Index (RSI) 54.11 52.53
Support Level $14.13 $6.93
Resistance Level $23.57 $7.19
Average True Range (ATR) 1.63 0.12
MACD -0.18 -0.01
Stochastic Oscillator 13.67 41.51

Price Performance

Historical Comparison
QTTB
AHRT

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About AHRT AH Realty Trust Inc. Common Stock

AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.

Share on Social Networks: